Watson to market authorized generic for ADHD
Watson Pharmaceuticals Inc. next spring plans to release an authorized generic version of Concerta (methylphenidate hydrochloride) extended-release tablets for the treatment of attention deficit hyperactivity disorder (ADHD). The company said Tuesday that its Watson Laboratories Inc.